Device Center Ombudsman Fields Fewer Complaints In 2005
This article was originally published in The Gray Sheet
Executive SummaryComplaints and disputes addressed to FDA's device center reached a three-year low last year, according to the ombudsman's annual report for 2005
You may also be interested in...
At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing EU rules that have been transposed into domestic legislation, it also wants the freedom to tailor its regulations in areas like clinical trials, advanced therapies and product labeling.
Health technology assessment body NICE is consulting on draft guidance that recommends Axonics' device for overactive bladder.